An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...

This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.

For the first time, scientists have successfully treated someone suffering from Huntington's disease, a fatal genetic illness ...

One of the most devastating inherited brain disorders, Huntington’s disease, has been treated successfully for the first time, according to doctors. The illness is passed down through families, ...

An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia and Parkinson’s, ...

Gene therapy is becoming a powerful way to treat challenging diseases that don’t respond to traditional treatments, and researchers now report the first success in modifying genes to slow Huntington’s ...

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

uniQure's AMT-130 receives Breakthrough Therapy designation from FDA for Huntington's disease, based on promising clinical trial data. uniQure N.V. announced that the U.S. FDA has granted Breakthrough ...

BRISBANE, Calif., Nov. 20, 2025 /PRNewswire/ -- ReviR Therapeutics, a biotech company focused on developing innovative treatments for neurogenetic diseases, announced today that it has been awarded a ...

The Food and Drug Administration on Monday approved Teva Pharmaceuticals’ new treatment for Huntington’s disease, a fatal degenerative disorder. Here are three things to know. 1. Austedo is intended ...